200 related articles for article (PubMed ID: 22030504)
1. An activin receptor-like kinase 5 inhibitor reduces collagen deposition in a rat dermal incision wound healing model.
Bian F; Render J; Ren XD; Chio C; Chan K; Boys M; Lala DS; Pocalyko D
Plast Reconstr Surg; 2011 Nov; 128(5):451e-459e. PubMed ID: 22030504
[TBL] [Abstract][Full Text] [Related]
2. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.
Shah M; Foreman DM; Ferguson MW
J Cell Sci; 1995 Mar; 108 ( Pt 3)():985-1002. PubMed ID: 7542672
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta3 promotes fascial wound healing in a new animal model.
Tyrone JW; Marcus JR; Bonomo SR; Mogford JE; Xia Y; Mustoe TA
Arch Surg; 2000 Oct; 135(10):1154-9. PubMed ID: 11030871
[TBL] [Abstract][Full Text] [Related]
4. Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase.
Bond JE; Kokosis G; Ren L; Selim MA; Bergeron A; Levinson H
Plast Reconstr Surg; 2011 Nov; 128(5):438e-450e. PubMed ID: 22030503
[TBL] [Abstract][Full Text] [Related]
5. Topical application of ALK5 inhibitor A-83-01 reduces burn wound contraction in rats by suppressing myofibroblast population.
Sun X; Kim YH; Phan TN; Yang BS
Biosci Biotechnol Biochem; 2014; 78(11):1805-12. PubMed ID: 25351330
[TBL] [Abstract][Full Text] [Related]
6. Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing.
Mani H; Sidhu GS; Kumari R; Gaddipati JP; Seth P; Maheshwari RK
Biofactors; 2002; 16(1-2):29-43. PubMed ID: 12515914
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction.
Tan SM; Zhang Y; Connelly KA; Gilbert RE; Kelly DJ
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1415-25. PubMed ID: 20154262
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats.
Lee RH; Efron DT; Tantry U; Stuelten C; Moldawer LL; Abouhamze A; Barbul A
Wound Repair Regen; 2000; 8(6):547-53. PubMed ID: 11208182
[TBL] [Abstract][Full Text] [Related]
9. The effect of suramin on healing adult rodent dermal wounds.
Chamberlain J; Shah M; Ferguson MW
J Anat; 1995 Feb; 186 ( Pt 1)(Pt 1):87-96. PubMed ID: 7649820
[TBL] [Abstract][Full Text] [Related]
10. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].
Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642
[TBL] [Abstract][Full Text] [Related]
11. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents.
Shah M; Foreman DM; Ferguson MW
J Cell Sci; 1994 May; 107 ( Pt 5)():1137-57. PubMed ID: 7929624
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.
Kapoun AM; Gaspar NJ; Wang Y; Damm D; Liu YW; O'young G; Quon D; Lam A; Munson K; Tran TT; Ma JY; Murphy A; Dugar S; Chakravarty S; Protter AA; Wen FQ; Liu X; Rennard SI; Higgins LS
Mol Pharmacol; 2006 Aug; 70(2):518-31. PubMed ID: 16707625
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
[TBL] [Abstract][Full Text] [Related]
15. Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis.
Jiang W; Yang CQ; Liu WB; Wang YQ; He BM; Wang JY
World J Gastroenterol; 2004 Jun; 10(11):1634-8. PubMed ID: 15162539
[TBL] [Abstract][Full Text] [Related]
16. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
Ferguson MW; O'Kane S
Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
[TBL] [Abstract][Full Text] [Related]
17. A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF-β Responsiveness by Inhibiting TGF-β Type I Receptor Serine/Threonine Kinase Activity.
Chen CL; Kao YC; Yang PH; Sung PJ; Wen ZH; Chen JJ; Huang YB; Chen PY
J Cell Biochem; 2016 Dec; 117(12):2800-2814. PubMed ID: 27153151
[TBL] [Abstract][Full Text] [Related]
18. The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor.
Broadley KN; Aquino AM; Hicks B; Ditesheim JA; McGee GS; Demetriou AA; Woodward SC; Davidson JM
Biotechnol Ther; 1989-1990; 1(1):55-68. PubMed ID: 2562644
[TBL] [Abstract][Full Text] [Related]
19. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
20. Improvement of the breaking strength of wound by combined treatment with recombinant human G-CSF, recombinant human M-CSF, and a TGF-beta1 receptor kinase inhibitor in rat skin.
Sugiyama K; Ishii G; Ochiai A; Esumi H
Cancer Sci; 2008 May; 99(5):1021-8. PubMed ID: 18380792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
